Complementary & alternative management of Parkinson's disease: an evidence-based review of eastern influenced practices
- PMID: 25360229
- PMCID: PMC4213533
- DOI: 10.14802/jmd.14009
Complementary & alternative management of Parkinson's disease: an evidence-based review of eastern influenced practices
Abstract
The prevalence of Parkinson's disease (PD) appears to be lower in Asia compared to the Western world. It is unclear if this is related to the ubiquitous use of traditional medicine in Eastern healthcare, but the use of complementary and alternative medicine (CAM) modalities in countries like Korea may be as high as 76%. Among patients with PD, herbal medicines, health supplement foods, and acupuncture are interventions which are increasingly used throughout the world. Countries like Korea, China, India, and Japan have long embraced and incorporated traditional medicine into modern management of conditions such as PD, but research into various CAM modalities remains in its infancy limiting evidence-based recommendations for many treatments. We reviewed the literature on CAM treatments for PD, focusing on mind-body interventions and natural products. Based on evidence limited to randomized-controlled trials we found that mind-body interventions are generally effective forms of physical activity that are likely to foster good adherence and may reduce disability associated with PD. Based on the current data, modalities like Tai Chi and dance are safe and beneficial in PD, but better studies are needed to assess the effects of other frequently used modalities such as yoga and acupuncture. Furthermore, despite centuries of experience using medicinal herbs and plants in Eastern countries, and despite substantial preclinical data on the beneficial effects of nutritional antioxidants as neuroprotective agents in PD, there is insufficient clinical evidence that any vitamin, food additive, or supplement, can improve motor function or delay disease progression in PD.
Keywords: Anti-oxidants; Complementary and alternative medicine; Herbal medicine; Korean medicine; Neutraceuticals; Parkinson’s disease.
Conflict of interest statement
The authors have no financial conflicts of interest.
Similar articles
-
A review of the clinical evidence for complementary and alternative therapies in Parkinson's disease.Curr Treat Options Neurol. 2014 Oct;16(10):314. doi: 10.1007/s11940-014-0314-5. Curr Treat Options Neurol. 2014. PMID: 25143234
-
Complementary and Alternative Medicine for Idiopathic Parkinson's Disease: An Evidence-Based Clinical Practice Guideline.Front Aging Neurosci. 2018 Oct 15;10:323. doi: 10.3389/fnagi.2018.00323. eCollection 2018. Front Aging Neurosci. 2018. PMID: 30374299 Free PMC article.
-
Traditional Chinese medicine for modern treatment of Parkinson's disease.Chin J Integr Med. 2017 Aug;23(8):635-640. doi: 10.1007/s11655-016-2537-7. Epub 2017 Jan 20. Chin J Integr Med. 2017. PMID: 28108911 Review.
-
Epidemiology of complementary and alternative medicine use in patients with Parkinson's disease.J Clin Neurosci. 2013 Aug;20(8):1062-7. doi: 10.1016/j.jocn.2012.10.022. Epub 2013 Jun 29. J Clin Neurosci. 2013. PMID: 23815871 Review.
-
The effects of yoga versus stretching and resistance training exercises on psychological distress for people with mild-to-moderate Parkinson's disease: study prxotocol for a randomized controlled trial.Trials. 2017 Nov 2;18(1):509. doi: 10.1186/s13063-017-2223-x. Trials. 2017. PMID: 29096672 Free PMC article. Clinical Trial.
Cited by
-
Effectiveness of Integrative Therapy for Parkinson's Disease Management.Front Aging Neurosci. 2019 Feb 26;11:40. doi: 10.3389/fnagi.2019.00040. eCollection 2019. Front Aging Neurosci. 2019. PMID: 30863304 Free PMC article.
-
Effectiveness and safety of herbal medicine Ukgansan for clinical symptoms in Parkinson's disease: A pilot, randomized, assessor-blinded clinical trial.Front Neurol. 2022 Nov 10;13:1025269. doi: 10.3389/fneur.2022.1025269. eCollection 2022. Front Neurol. 2022. PMID: 36438946 Free PMC article.
-
A nationwide retrospective cohort study of the association between acupuncture exposure and clinical outcomes of idiopathic Parkinson's disease using health insurance claim data in South Korea.Integr Med Res. 2025 Jun;14(2):101146. doi: 10.1016/j.imr.2025.101146. Epub 2025 Apr 22. Integr Med Res. 2025. PMID: 40475038 Free PMC article.
-
Challenges in Managing Nonmotor Symptoms of Parkinson's Disease in Low-Resourced Settings with Unavailability of Newer Drugs.Mov Disord Clin Pract. 2024 Feb;11(2):123-128. doi: 10.1002/mdc3.13957. Epub 2024 Jan 3. Mov Disord Clin Pract. 2024. PMID: 38168114 Free PMC article. No abstract available.
-
Novel Neuroprotective Effects of Melanin-Concentrating Hormone in Parkinson's Disease.Mol Neurobiol. 2017 Dec;54(10):7706-7721. doi: 10.1007/s12035-016-0258-8. Epub 2016 Nov 14. Mol Neurobiol. 2017. PMID: 27844281
References
-
- Pringsheim T, Jette N, Frolkis A, Steeves TD. The prevalence of Parkinson’s disease: a systematic review and metaanalysis. Mov Disord. 2014 [Epub ahead of print] - PubMed
-
- Global Parkinson’s Disease Survey Steering Committee Factors impacting on quality of life in Parkinson’s disease: results from an international survey. Mov Disord. 2002;17:60–67. - PubMed
-
- Hely MA, Morris JG, Reid WG, Trafficante R. Sydney Multicenter Study of Parkinson’s disease: non-L-dopa-responsive problems dominate at 15 years. Mov Disord. 2005;20:190–199. - PubMed
-
- Rajendran PR, Thompson RE, Reich SG. The use of alternative therapies by patients with Parkinson’s disease. Neurology. 2001;57:790–794. - PubMed
-
- Kim JY, Jeon BS. Complementary and alternative medicine in Parkinson’s disease patients in Korea. Curr Neurol Neurosci Rep. 2012;12:631–632. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous